title: What will be the role of first-trimester ultrasound if cell-free DNA screening for aneuploidy becomes routine?
authors.affiliation: Department of Obstetrics and Gynecology, Wright State University, Dayton, OH, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Sonek
authors.forename: H S
authors.initials: HS
authors.lastname: Cuckle
mesh_terms: D000782:Aneuploidy; D002474:Cell-Free System; D000013:Congenital Abnormalities / Q000097:blood / Q000000981:diagnostic imaging / Q000191:economics; D003362:Cost-Benefit Analysis; D004247:DNA / Q000097:blood*; D004314:Down Syndrome / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000191:economics; D005260:Female; D005865:Gestational Age; D006801:Humans; D062145:Maternal Serum Screening Tests / Q000191:economics; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000000981:diagnostic imaging / Q000191:economics; D011261:Pregnancy Trimester, First; D016216:Ultrasonography, Prenatal / Q000191:economics; D014481:United States
chemical_list: D004247:DNA